S M Bode - JoVE Visualize

Showing results (31-40 of 62) with videos related to

Pageof 7

Sort By:

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 11, 1999

L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatmentS M Bode-Böger, R H Böger, M Löffler, et al.

Journal of the American College of Cardiology|November 11, 1998

Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive diseaseR H Böger, S M Bode-Böger, W Thiele, et al.

Atherosclerosis|January 27, 1999

Lovastatin maintains nitric oxide--but not EDHF-mediated endothelium-dependent relaxation in the hypercholesterolemic rabbit carotid arteryR P Brandes, A Behra, C Lebherz, et al.

Atherosclerosis|April 17, 1998

Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbitsR H Böger, S M Bode-Böger, S Kienke, et al.

British Journal of Clinical Pharmacology|December 1, 1996

Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acidR H Böger, S M Bode-Böger, P Kramme, et al.

Clinical and Experimental Pharmacology & Physiology|January 1, 1996

Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in ratsR H Boger, S M Bode-Boger, U Gerecke, et al.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 29, 2000

Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosisS M Bode-Böger, R H Böger, J T Kielstein, et al.

International Journal of Clinical Pharmacology and Therapeutics|August 1, 1996

Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertensionR H Böger, A Mügge, S M Bode-Böger, et al.

The Journal of Clinical Investigation|December 15, 1996

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled studyR H Böger, C Skamira, S M Bode-Böger, et al.

Clinical Science (London, England : 1979)|May 1, 1993

Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in manR H Böger, S M Bode-Böger, F M Gutzki, et al.

Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:

Pageof 7

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 11, 1999

L-arginine stimulates NO-dependent vasodilation in healthy humans--effect of somatostatin pretreatmentS M Bode-Böger, R H Böger, M Löffler, et al.

Journal of the American College of Cardiology|November 11, 1998

Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive diseaseR H Böger, S M Bode-Böger, W Thiele, et al.

Atherosclerosis|January 27, 1999

Lovastatin maintains nitric oxide--but not EDHF-mediated endothelium-dependent relaxation in the hypercholesterolemic rabbit carotid arteryR P Brandes, A Behra, C Lebherz, et al.

Atherosclerosis|April 17, 1998

Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbitsR H Böger, S M Bode-Böger, S Kienke, et al.

British Journal of Clinical Pharmacology|December 1, 1996

Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acidR H Böger, S M Bode-Böger, P Kramme, et al.

Clinical and Experimental Pharmacology & Physiology|January 1, 1996

Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in ratsR H Boger, S M Bode-Boger, U Gerecke, et al.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 29, 2000

Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosisS M Bode-Böger, R H Böger, J T Kielstein, et al.

International Journal of Clinical Pharmacology and Therapeutics|August 1, 1996

Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertensionR H Böger, A Mügge, S M Bode-Böger, et al.

The Journal of Clinical Investigation|December 15, 1996

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled studyR H Böger, C Skamira, S M Bode-Böger, et al.

Clinical Science (London, England : 1979)|May 1, 1993

Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in manR H Böger, S M Bode-Böger, F M Gutzki, et al.

Pageof 7